Invitation to Observe Medical ASA's first half year 2024 presentation and Q&A
Oslo, August 19, 2024 - Observe Medical ("the Company" or "Observe Medical") will release its results for the first half year 2024 on Monday, 26 Augsut 2024. The presentation will be published on NewsWeb and the Company's website at 07:00 CET on the same day.
The Company will host a presentation and Q&A session at 10:00 CET on the same day. Personal attendance is welcomed at Carnegie's offices at Aker Brygge, Fjordalleen 16.
The session will also be streamed via webcast. To register and follow the presentation online, please copy and paste the following link into your browser, click attend and register your e-mail:
https://channel.royalcast.com/landingpage/hegnarmedia/20240826_1/
After the live event, the presentation and recording will be made available under the Investor Relations section on the Company's website,
https://observemedical.com/investor-relations/
For further information, please contact:
Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and commercialisation of its broad portfolio of medical technology products, mainly in urine measurement and ultrasound, in combination with targeted M&A and distribution. Observe Medical is working with a network of leading distributors to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available at www.observemedical.com.
Tags: